142 related articles for article (PubMed ID: 2577154)
1. Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin.
Thierry AR; Jorgensen TJ; Forst D; Belli JA; Dritschilo A; Rahman A
Cancer Commun; 1989; 1(5):311-6. PubMed ID: 2577154
[TBL] [Abstract][Full Text] [Related]
2. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes.
Thierry AR; Vigé D; Coughlin SS; Belli JA; Dritschilo A; Rahman A
FASEB J; 1993 Apr; 7(6):572-9. PubMed ID: 8097173
[TBL] [Abstract][Full Text] [Related]
3. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin.
Sadasivan R; Morgan R; Fabian C; Stephens R
Cancer Lett; 1991 May; 57(2):165-71. PubMed ID: 1673873
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes.
Oudard S; Thierry A; Jorgensen TJ; Rahman A
Cancer Chemother Pharmacol; 1991; 28(4):259-65. PubMed ID: 1678995
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
7. Effect of liposomes on P-glycoprotein function in multidrug resistant cells.
Thierry AR; Dritschilo A; Rahman A
Biochem Biophys Res Commun; 1992 Sep; 187(2):1098-105. PubMed ID: 1356335
[TBL] [Abstract][Full Text] [Related]
8. Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100).
Sognier MA; Zhang Y; Eberle RL; Sweet KM; Altenberg GA; Belli JA
Biochem Pharmacol; 1994 Jul; 48(2):391-401. PubMed ID: 7914406
[TBL] [Abstract][Full Text] [Related]
9. A lack of adriamycin (ADR) resistance in Chinese hamster ovary (CHO) cells overexpressing P-glycoprotein (Pgp) following in vitro exposure to fractionated X-irradiation.
Whelan RD; Hosking LK; Hill BT
Biochem Soc Trans; 1991 Apr; 19(2):125S. PubMed ID: 1679723
[No Abstract] [Full Text] [Related]
10. Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines.
Sognier MA; Zhang Y; Eberle RL; Belli JA
Biochem Pharmacol; 1992 Nov; 44(9):1859-68. PubMed ID: 1360213
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferase and P-glycoprotein in multidrug resistant Chinese hamster cells.
Medh RD; Gupta V; Zhang Y; Awasthi YC; Belli JA
Biochem Pharmacol; 1990 Jun; 39(11):1641-5. PubMed ID: 1971511
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.
Taylor CW; Dalton WS; Parrish PR; Gleason MC; Bellamy WT; Thompson FH; Roe DJ; Trent JM
Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells.
Schuurhuis GJ; Broxterman HJ; Cervantes A; van Heijningen TH; de Lange JH; Baak JP; Pinedo HM; Lankelma J
J Natl Cancer Inst; 1989 Dec; 81(24):1887-92. PubMed ID: 2574239
[TBL] [Abstract][Full Text] [Related]
14. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
Krishna R; Mayer LD
Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743
[TBL] [Abstract][Full Text] [Related]
15. Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cells.
Hofsli E; Nissen-Meyer J
Int J Cancer; 1989 Jul; 44(1):149-54. PubMed ID: 2568347
[TBL] [Abstract][Full Text] [Related]
16. High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells.
Muller C; Laval F; Soues S; Birck C; Charcosset JY
Biochem Pharmacol; 1992 May; 43(10):2091-102. PubMed ID: 1376119
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
Huet S; Schott B; Robert J
Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
[TBL] [Abstract][Full Text] [Related]
18. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
Lee WP; Lee CL; Kao MC
Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
